Year: 2020
Type: dissertation
Study design: Observational Study
Abstract: Cerebrovascular dysfunction is a pathological change that occurs in neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. Whether cerebrovascular dysfunction is a cause, consequence, or co-pathology of neurodegeneration remains a topic of research debate. There is, however, an agreement on the important role of cerebrovascular measures in neurodegeneration progression. This thesis investigated arterial spin-labeled (ASL) and blood oxygenation level-dependent (BOLD) MRI to characterize cerebral hemodynamics in adults with a range of clinical symptoms related to neurodegeneration. The first study of this thesis developed an ASL postprocessing quality enhancement algorithm. My proposed algorithm resulted in higher quality blood flow images, i.e. higher similarity with nuclear medicine-based blood flow imaging. I conclude that there is an opportunity to implement this algorithm to improve clinical ASL. The second study investigated whether a single ASL summary measure can distinguish cognitively unimpaired, mild cognitive impairment, and Alzheimer’s disease groups. I found that spatial variability of blood flow images is increased in the cognitively impaired groups. Moreover, spatial variability of blood flow contributed to cognitive group classification after adjusting for established neuroimaging markers of Alzheimer’s, e.g. structural changes and protein markers. The third study investigated the temporal variability of BOLD signal among adults with Parkinson’s disease. I found that temporal variability of blood flow alongside with dopamine deficiency explain between-subject variability in clinical symptoms. The findings of this thesis 1) help to establish best practices in postprocessing of ASL and BOLD images in cohorts with neurodegenerative diseases, and 2) reveal that non-invasive MRI-based hemodynamic features can be used to explain clinical symptoms in the spectrum of neurodegeneration. In conclusion, this thesis capitalized on the versatility of MRI to produce cerebral hemodynamic image contrast that can characterise the heterogeneity of neurodegenerative diseases.
Source: TSpace (University of Toronto)
Author: Zahra Shirzadi
Institution: University of Toronto
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: U.S. Department of Defense, Michael J. Fox Foundation for Parkinson's Research, Alzheimer's Association, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Biogen, University of Southern California, Meso Scale Diagnostics, Alzheimer's Disease Neuroimaging Initiative, BioClinica, Novartis Pharmaceuticals Corporation, Northern California Institute for Research and Education, Eisai, Servier, H. Lundbeck A/S, IXICO, National Institutes of Health, Genentech, Canadian Institutes of Health Research, National Institute on Aging
Awards: G2423387114, G2522063444, G2835601961, G29951154, G3870774570, G4119534169, G4475667458, EFFECTS OF TRAUMATIC BRAIN INJURY (TBI) AND POST TRAUMATIC STRESS DISORDER (PTSD) ON ALZHEIMER'S DISEASE (AD) IN VETERANS USING IMAGING AND BIOMARKERS IN THE AD NEUROIMAGING INITIATIVE (ADNI)", Alzheimer's Disease Neuroimaging Initiative, G9000122335
OpenAlex ID: W3154722787
